Background Aberrant crypt foci of the colon are possible precursorsof adenoma and cancer, but these lesions have been studied mainlyin surgical specimens from patients who already had colon cancer.
Methods Using magnifying endoscopy, we studied the prevalence,number, size, and dysplastic features of aberrant crypt fociand their distribution according to age in 171 normal subjects,131 patients with adenoma, and 48 patients with colorectal cancer.We also prospectively examined the prevalence of aberrant cryptfoci in 11 subjects (4 normal subjects, 6 with adenoma, and1 with cancer) before and after the administration of 100 mgof sulindac three times a day for 8 to 12 months and comparedthe results with those in 9 untreated subjects (4 normal subjectsand 5 with adenoma). All 20 subjects had aberrant crypt fociat base line.
Results We identified 3155 aberrant crypt foci, 161 of whichwere dysplastic; the prevalence and number increased with age.There were significant (P<0.001) correlations between thenumber of aberrant crypt foci, the presence of dysplastic foci,the size of the foci, and the number of adenomas. After sulindactherapy, the number of foci decreased, disappearing in 7 of11 subjects. In the untreated control group, the number of fociwas unchanged in eight subjects and slightly increased in one(P<0.001 for the difference between the groups).
Conclusions Aberrant crypt foci, particularly those that arelarge and have dysplastic features, may be precursors of adenomaand cancer.
Source Information
From the Fourth Department of Internal Medicine (T.T., S.K., Y.T., M.O., S.S., J.K., K.K., Y.N.) and the Department of Public Health (H.M.), Sapporo Medical University, Sapporo; and Muroran Shinnittetsu Hospital, Muroran (S.N.) — both in Japan.
Address reprint requests to Dr. Niitsu at the Fourth Department of Internal Medicine, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Japan.
Ahlquist, D. A., Sargent, D. J., Loprinzi, C. L., Levin, T. R., Rex, D. K., Ahnen, D. J., Knigge, K., Lance, M. P., Burgart, L. J., Hamilton, S. R., Allison, J. E., Lawson, M. J., Devens, M. E., Harrington, J. J., Hillman, S. L.
(2008). Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia. ANN INTERN MED
149: 441-450
[Abstract][Full Text]
Lance, P., Hamilton, S. R.
(2008). Comment re: "Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention" and "Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial". Cancer Prevention Research
1: 216-216
[Full Text]
Lance, P., Hamilton, S. R.
(2008). Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention. Cancer Prevention Research
1: 4-8
[Full Text]
Cho, N. L., Redston, M., Zauber, A. G., Carothers, A. M., Hornick, J., Wilton, A., Sontag, S., Nishioka, N., Giardiello, F. M., Saltzman, J. R., Gostout, C., Eagle, C. J., Hawk, E. T., Bertagnolli, M. M.
(2008). Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial. Cancer Prevention Research
1: 21-31
[Abstract][Full Text]
Kim, J., Ng, J., Arozulllah, A., Ewing, R., Llor, X., Carroll, R. E., Benya, R. V.
(2008). Aberrant Crypt Focus Size Predicts Distal Polyp Histopathology. Cancer Epidemiol. Biomarkers Prev.
17: 1155-1162
[Abstract][Full Text]
Kukitsu, T., Takayama, T., Miyanishi, K., Nobuoka, A., Katsuki, S., Sato, Y., Takimoto, R., Matsunaga, T., Kato, J., Sonoda, T., Sakamaki, S., Niitsu, Y.
(2008). Aberrant Crypt Foci as Precursors of the Dysplasia-Carcinoma Sequence in Patients with Ulcerative Colitis. Clin. Cancer Res.
14: 48-54
[Abstract][Full Text]
Xiao, H., Hao, X., Simi, B., Ju, J., Jiang, H., Reddy, B. S., Yang, C. S.
(2008). Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis
29: 113-119
[Abstract][Full Text]
Matusiak, D., Benya, R. V.
(2007). CYP27A1 and CYP24 Expression as a Function of Malignant Transformation in the Colon. J. Histochem. Cytochem.
55: 1257-1264
[Abstract][Full Text]
Schmelz, E. M., Xu, H., Sengupta, R., Du, J., Banerjee, S., Sarkar, F. H., Rishi, A. K., Majumdar, A. P.N.
(2007). Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein. Cancer Res.
67: 5389-5396
[Abstract][Full Text]
Greenspan, E. J., Cyr, J. L., Pleau, D. C., Levine, J., Rajan, T. V., Rosenberg, D. W., Heinen, C. D.
(2007). Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis
28: 769-776
[Abstract][Full Text]
Fichera, A., Little, N., Jagadeeswaran, S., Dougherty, U., Sehdev, A., Mustafi, R., Cerda, S., Yuan, W., Khare, S., Tretiakova, M., Gong, C., Tallerico, M., Cohen, G., Joseph, L., Hart, J., Turner, J. R., Bissonnette, M.
(2007). Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Res.
67: 827-835
[Abstract][Full Text]
Glebov, O. K., Rodriguez, L. M., Soballe, P., DeNobile, J., Cliatt, J., Nakahara, K., Kirsch, I. R.
(2006). Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa.. Cancer Epidemiol. Biomarkers Prev.
15: 2253-2262
[Abstract][Full Text]
Glebov, O. K., Rodriguez, L. M., Lynch, P., Patterson, S., Lynch, H., Nakahara, K., Jenkins, J., Cliatt, J., Humbyrd, C.-J., DeNobile, J., Soballe, P., Gallinger, S., Buchbinder, A., Gordon, G., Hawk, E., Kirsch, I. R.
(2006). Celecoxib treatment alters the gene expression profile of normal colonic mucosa.. Cancer Epidemiol. Biomarkers Prev.
15: 1382-1391
[Abstract][Full Text]
Greenspan, E. J., Jablonski, M. A., Rajan, T. V., Levine, J., Belinsky, G. S., Rosenberg, D. W.
(2006). Epigenetic alterations in RASSF1A in human aberrant crypt foci. Carcinogenesis
27: 1316-1322
[Abstract][Full Text]
Cohen, G., Mustafi, R., Chumsangsri, A., Little, N., Nathanson, J., Cerda, S., Jagadeeswaran, S., Dougherty, U., Joseph, L., Hart, J., Yerian, L., Tretiakova, M., Yuan, W., Obara, P., Khare, S., Sinicrope, F. A., Fichera, A., Boss, G. R., Carroll, R., Bissonnette, M.
(2006). Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci. Cancer Res.
66: 5656-5664
[Abstract][Full Text]
Ross, S. A., Finley, J. W., Milner, J. A.
(2006). Allyl Sulfur Compounds from Garlic Modulate Aberrant Crypt Formation. J. Nutr.
136: 852S-854S
[Abstract][Full Text]
Roy, H. K., Kim, Y. L., Liu, Y., Wali, R. K., Goldberg, M. J., Turzhitsky, V., Horwitz, J., Backman, V.
(2006). Risk Stratification of Colon Carcinogenesis through Enhanced Backscattering Spectroscopy Analysis of the Uninvolved Colonic Mucosa. Clin. Cancer Res.
12: 961-968
[Abstract][Full Text]
Matusiak, D., Murillo, G., Carroll, R. E., Mehta, R. G., Benya, R. V.
(2005). Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in Normal and Malignant Human Colon. Cancer Epidemiol. Biomarkers Prev.
14: 2370-2376
[Abstract][Full Text]
Roy, H. K., Kim, Y. L., Wali, R. K., Liu, Y., Koetsier, J., Kunte, D. P., Goldberg, M. J., Backman, V.
(2005). Spectral Markers in Preneoplastic Intestinal Mucosa: An Accurate Predictor of Tumor Risk in the MIN Mouse. Cancer Epidemiol. Biomarkers Prev.
14: 1639-1645
[Abstract][Full Text]
Badger, T. M., Ronis, M. J. J., Simmen, R. C. M., Simmen, F. A.
(2005). Soy Protein Isolate and Protection Against Cancer. J. Am. Coll. Nutr.
24: 146S-149S
[Abstract][Full Text]
Dong, M., Johnson, M., Rezaie, A., Ilsley, J. N.M., Nakanishi, M., Sanders, M. M., Forouhar, F., Levine, J., Montrose, D. C., Giardina, C., Rosenberg, D. W.
(2005). Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon Tumorigenesis. Clin. Cancer Res.
11: 2265-2271
[Abstract][Full Text]
Rudolph, R. E., Dominitz, J. A., Lampe, J. W., Levy, L., Qu, P., Li, S. S., Lampe, P. D., Bronner, M. P., Potter, J. D.
(2005). Risk Factors for Colorectal Cancer in Relation to Number and Size of Aberrant Crypt Foci in Humans. Cancer Epidemiol. Biomarkers Prev.
14: 605-608
[Abstract][Full Text]
Ma, D. W.L., Finnell, R. H., Davidson, L. A., Callaway, E. S., Spiegelstein, O., Piedrahita, J. A., Salbaum, J. M., Kappen, C., Weeks, B. R., James, J., Bozinov, D., Lupton, J. R., Chapkin, R. S.
(2005). Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis. Cancer Res.
65: 887-897
[Abstract][Full Text]
Hawk, E. T., Levin, B.
(2005). Colorectal Cancer Prevention. JCO
23: 378-391
[Abstract][Full Text]
Wu, B., Iwakiri, R., Ootani, A., Tsunada, S., Fujise, T., Sakata, Y., Sakata, H., Toda, S., Fujimoto, K.
(2004). Dietary Corn Oil Promotes Colon Cancer by Inhibiting Mitochondria-Dependent Apoptosis in Azoxymethane-Treated Rats. Exp. Biol. Med.
229: 1017-1025
[Abstract][Full Text]
Baker, K, Zhang, Y, Jin, C, Jass, J R
(2004). Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?. J. Clin. Pathol.
57: 1089-1093
[Abstract][Full Text]
Nambiar, P. R., Nakanishi, M., Gupta, R., Cheung, E., Firouzi, A., Ma, X.-J., Flynn, C., Dong, M., Guda, K., Levine, J., Raja, R., Achenie, L., Rosenberg, D. W.
(2004). Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer. Cancer Res.
64: 6394-6401
[Abstract][Full Text]
Kelloff, G. J., Schilsky, R. L., Alberts, D. S., Day, R. W., Guyton, K. Z., Pearce, H. L., Peck, J. C., Phillips, R., Sigman, C. C.
(2004). Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs. Clin. Cancer Res.
10: 3908-3918
[Full Text]
Ray, R., Cabal-Manzano, R., Moser, A. R., Waldman, T., Zipper, L. M., Aigner, A., Byers, S. W., Riegel, A. T., Wellstein, A.
(2003). Up-Regulation of Fibroblast Growth Factor-Binding Protein, by {beta}-Catenin during Colon Carcinogenesis. Cancer Res.
63: 8085-8089
[Abstract][Full Text]
Hawk, E T, Viner, J L
(2003). Aspirin: still learning about the wonder drug. Gut
52: 1535-1536
[Full Text]
Shpitz, B, Klein, E, Buklan, G, Neufeld, D, Nissan, A, Freund, H R, Grankin, M, Bernheim, J
(2003). Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer. Gut
52: 1598-1601
[Abstract][Full Text]
Pretlow, T. P., Edelmann, W., Kucherlapati, R., Pretlow, T. G., Augenlicht, L. H.
(2003). Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele. Am. J. Pathol.
163: 1757-1763
[Abstract][Full Text]
Luo, L., Li, B., Pretlow, T. P.
(2003). DNA Alterations in Human Aberrant Crypt Foci and Colon Cancers by Random Primed Polymerase Chain Reaction. Cancer Res.
63: 6166-6169
[Abstract][Full Text]
Ochiai, M., Ushigome, M., Fujiwara, K., Ubagai, T., Kawamori, T., Sugimura, T., Nagao, M., Nakagama, H.
(2003). Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine. Am. J. Pathol.
163: 1607-1614
[Abstract][Full Text]
Corpet, D. E., Pierre, F.
(2003). Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System. Cancer Epidemiol. Biomarkers Prev.
12: 391-400
[Abstract][Full Text]
Yang, K., Fan, K., Kurihara, N., Shinozaki, H., Rigas, B., Augenlicht, L., Kopelovich, L., Edelmann, W., Kucherlapati, R., Lipkin, M.
(2003). Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis
24: 605-611
[Abstract][Full Text]
Mcdorman, K. S., Chandra, S., Hooth, M. J., Hester, S. D., Schoonhoven, R., Wolf, D. C.
(2003). Induction of Transitional Cell Hyperplasia in the Urinary Bladder and Aberrant Crypt Foci in the Colon of Rats Treated with Individual and a Mixture of Drinking Water Disinfection By-Products. Toxicol Pathol
31: 235-242
[Abstract]
Wali, R. K., Khare, S., Tretiakova, M., Cohen, G., Nguyen, L., Hart, J., Wang, J., Wen, M., Ramaswamy, A., Joseph, L., Sitrin, M., Brasitus, T., Bissonnette, M.
(2002). Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin. Cancer Epidemiol. Biomarkers Prev.
11: 1653-1662
[Abstract][Full Text]
Luebeck, E. G., Moolgavkar, S. H.
(2002). Multistage carcinogenesis and the incidence of colorectal cancer. Proc. Natl. Acad. Sci. USA
99: 15095-15100
[Abstract][Full Text]
Wali, R. K., Stoiber, D., Nguyen, L., Hart, J., Sitrin, M. D., Brasitus, T., Bissonnette, M.
(2002). Ursodeoxycholic Acid Inhibits the Initiation and Postinitiation Phases of Azoxymethane-induced Colonic Tumor Development. Cancer Epidemiol. Biomarkers Prev.
11: 1316-1321
[Abstract][Full Text]
Nascimbeni, R., Donato, F., Ghirardi, M., Mariani, P., Villanacci, V., Salerni, B.
(2002). Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon Cancer: A Risk Assessment Using Aberrant Crypt Foci. Cancer Epidemiol. Biomarkers Prev.
11: 753-757
[Abstract][Full Text]
Bernstein, H., Holubec, H., Warneke, J. A., Garewal, H., Earnest, D. L., Payne, C. M., Roe, D. J., Cui, H., Jacobson, E. L., Bernstein, C.
(2002). Patchy Field Defects of Apoptosis Resistance and Dedifferentiation in Flat Mucosa of Colon Resections From Colon Cancer Patients. Ann. Surg. Oncol.
9: 505-517
[Abstract][Full Text]
O'Shaughnessy, J. A., Kelloff, G. J., Gordon, G. B., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S., Nelson, W. G., Meyskens, F. L., Alberts, D. S., Follen, M., Rustgi, A. K., Papadimitrakopoulou, V., Scardino, P. T., Gazdar, A. F., Wattenberg, L. W., Sporn, M. B., Sakr, W. A., Lippman, S. M., Von Hoff, D. D.
(2002). Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia. Clin. Cancer Res.
8: 314-346
[Abstract][Full Text]
Keller, J. J., Offerhaus, G. J. A., Drillenburg, P., Caspers, E., Musler, A., Ristimaki, A., Giardiello, F. M.
(2001). Molecular Analysis of Sulindac-resistant Adenomas in Familial Adenomatous Polyposis. Clin. Cancer Res.
7: 4000-4007
[Abstract][Full Text]
Hamilton, S. R.
(2001). Origin of Colorectal Cancers in Hyperplastic Polyps and Serrated Adenomas: Another Truism Bites the Dust. JNCI J Natl Cancer Inst
93: 1282-1283
[Full Text]
Giovannucci, E.
(2001). An Updated Review of the Epidemiological Evidence that Cigarette Smoking Increases Risk of Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev.
10: 725-731
[Abstract][Full Text]
Latham, P, Lund, E K, Brown, J C, Johnson, I T
(2001). Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. Gut
49: 97-105
[Abstract][Full Text]
Gökmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica, Z., Fields, A. P.
(2001). Elevated Protein Kinase C {beta}II Is an Early Promotive Event in Colon Carcinogenesis. Cancer Res.
61: 1375-1381
[Abstract][Full Text]
Gee, J.M., Noteborn, H.P.J.M., Polley, A.C.J., Johnson, I.T.
(2000). Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein. Carcinogenesis
21: 2255-2259
[Abstract][Full Text]
Papanikolaou, A., Wang, Q.-S., Papanikolaou, D., Whiteley, H. E., Rosenberg, D. W.
(2000). Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis
21: 1567-1572
[Abstract][Full Text]
Kopreski, M. S., Benko, F. A., Borys, D. J., Khan, A., McGarrity, T. J., Gocke, C. D.
(2000). Somatic Mutation Screening: Identification of Individuals Harboring K-ras Mutations With the Use of Plasma DNA. JNCI J Natl Cancer Inst
92: 918-923
[Abstract][Full Text]
Wargovich, M. J., Jimenez, A., McKee, K., Steele, V. E., Velasco, M., Woods, J., Price, R., Gray, K., Kelloff, G. J.
(2000). Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis
21: 1149-1155
[Abstract][Full Text]
Keith, R. L., Miller, Y. E., Gemmill, R. M., Drabkin, H. A., Dempsey, E. C., Kennedy, T. C., Prindiville, S., Franklin, W. A.
(2000). Angiogenic Squamous Dysplasia in Bronchi of Individuals at High Risk for Lung Cancer. Clin. Cancer Res.
6: 1616-1625
[Abstract][Full Text]
Singh, P., Velasco, M., Given, R., Wargovich, M., Varro, A., Wang, T. C.
(2000). Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am. J. Physiol. Gastrointest. Liver Physiol.
278: G390-G399
[Abstract][Full Text]
Bartoli, R, Fernandez-Banares, F, Navarro, E, Castella, E, Mane, J, Alvarez, M, Pastor, C, Cabre, E, Gassull, M A
(2000). Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis. Gut
46: 191-199
[Abstract][Full Text]
Fenoglio-Preiser, C. M., Noffsinger, A.
(1999). Review Article: Aberrant Crypt Foci: A Review. Toxicol Pathol
27: 632-642
McCaskill-Stevens, W., Hawk, E. T., Flynn, P. J., Lippman, S. M.
(1999). National Cancer Institute-Supported Cancer Chemoprevention Research: Coming of Age. JCO
17: 53-62
[Full Text]
Parnaud, G., Tache, S., Peiffer, G., Corpet, D. E.
(1999). Polyethylene-glycol Suppresses Colon Cancer and Causes Dose-dependent Regression of Azoxymethane-induced Aberrant Crypt Foci in Rats. Cancer Res.
59: 5143-5147
[Abstract][Full Text]
Shiff, S. J., Rigas, B.
(1999). The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (NSAIDs). JEM
190: 445-450
[Full Text]
Murray, N. R., Davidson, L. A., Chapkin, R. S., Clay Gustafson, W., Schattenberg, D. G., Fields, A. P.
(1999). Overexpression of Protein Kinase C beta II Induces Colonic Hyperproliferation and Increased Sensitivity to Colon Carcinogenesis. JCB
145: 699-711
[Abstract][Full Text]
Corpet, D. E., Parnaud, G.
(1999). Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis
20: 915-918
[Abstract][Full Text]
Previous
